ArticleJournal of experimental & clinical cancer research : CR2022

LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer.

Donatella Delle Cave et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.